- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01854788
3 Airway Clearance Techniques in Non Cystic Fibrosis Bronchiectasis
May 13, 2013 updated by: Beatriz Herrero, Hospital Clinic of Barcelona
A Comparative Study of Three Airway Clearance Techniques With Different Autonomy Degrees in Non Cystic Fibrosis Bronchiectasis: Randomized Cross-over Trial.
Study design: a randomized, crossover trial.
Each patient performed three different airway clearance techniques (Autogenic drainage, slow expiratory with glottis opened in lateral posture [ELTGOL], temporary- positive expiratory pressure [T-PEP] with not similar autonomy degree in a randomized order.
Each technique were applied in 3 sessions during one week at alternate days (Monday /Wednesday/Friday or Tuesday/Thursday/Saturday).
The time spent in each bronchial session was 40 minutes.
Seven days were the wash-out time period between the different techniques.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08029
- Hospital Clínic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- - Non Cystic Fibrosis bronchiectasis diagnosed by High Resolution Computed Tomographic
- - Mean sputum production ≥ 15 ml /24h
- - Clinical stability in the last 6 weeks
- - Not carrying out regular chest physiotherapy
- - Forced expiratory volume in 1 second ≥ 30% pred. ; Forced Vital Capacity ≥ 45% pred. and peak expiratory flow >270 L/s
Exclusion Criteria:
- - Smoker or non-smoker form less than 2 years
- - Cystic fibrosis
- - Active tuberculosis or sarcoidosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Autogenic drainage
All patients performed all interventions in a randomized order.
Each technique was applied in 3 non consecutively sessions during one week.
The time spent during the session was 40 minutes
|
It was performed following J. Chevallier recommendations.In this trial it was considered a self-administrated technique because physiotherapist only gave oral advice in order to ensure a correct performance of the technique.
|
Active Comparator: Slow expiration with glottis opened in lateral posture
All patients performed all interventions in a randomized order.Each technique was applied in 3 non consecutively sessions during one week.
The time spent during the session was 40 minutes
|
It was performed following Postiaux´s recommendations.
In this trial the technique was considered active-assisted because the physiotherapy played a role important in their execution.
Other Names:
|
Active Comparator: Temporary-Positive Expiratory Pressure
All patients performed all interventions in a randomized order.
Each technique was applied in 3 non consecutively sessions during one week.
The time spent during the session was 40 minutes
|
The diaphragmatic breathing was required for this technique whereas patients remain seated in front of the device with a nose clip.
The inspiratory /expiratory ratio was 1:2.It was taken into account as a device-administrated technique for this trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight of sputum expectorated during each airway clearance therapy session
Time Frame: 40 minutes
|
Wet weight sputum production were recollected in one pre-weighted containers.
It was measured in grams.
|
40 minutes
|
Weight of sputum expectorated 24 hours post each bronchial session
Time Frame: 24 hours
|
Wet weight sputum production were recollected in one pre-weighted containers.
It was measured in grams.
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Saint George Respiratory Questionnaire (SGRQ)
Time Frame: Change from baseline at 5 weeks
|
Saint George Respiratory Questionnaire (SGRQ) is a self-completed health-related quality of life questionnaire.It was validated in bronchiectasis.
It was administrated at the start and at the end of trial.
|
Change from baseline at 5 weeks
|
Leicester Cough Questionnaire (LCQ)
Time Frame: Changes from baseline arm to 1 week
|
Leicester Cough Questionnaire is a self-completed quality of life measure of the impact of cough severity.
It was validated in bronchiectasis.
It was administrated at the start and at the end of each technique.
|
Changes from baseline arm to 1 week
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lung function measured by simple spirometry: forced expiratory volume in 1 second, Forced vital capacity, Forced expiratory flow 25-75
Time Frame: Change from baseline arm to 1 week
|
Change from baseline arm to 1 week
|
|
Likert test
Time Frame: Change from baseline arm to 1 week
|
It is a patient´s preferences measure.
The questionnaire consists of a package of simple questions about the airway clearance techniques.
|
Change from baseline arm to 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Beatriz Herrero, Phy, Hospital Clinic of Barcelona
- Study Director: Eva Polverino, Doctor, Hospital Clinic of Barcelona
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Herrero-Cortina B, Alcaraz-Serrano V, Torres A, Polverino E. Reliability and Minimum Important Difference of Sputum Weight in Bronchiectasis. Respir Care. 2020 Oct;65(10):1478-1487. doi: 10.4187/respcare.07175. Epub 2020 Feb 18.
- Herrero-Cortina B, Vilaro J, Marti D, Torres A, San Miguel-Pagola M, Alcaraz V, Polverino E. Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy. 2016 Dec;102(4):357-364. doi: 10.1016/j.physio.2015.07.005. Epub 2015 Dec 1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
August 8, 2012
First Submitted That Met QC Criteria
May 13, 2013
First Posted (Estimate)
May 16, 2013
Study Record Updates
Last Update Posted (Estimate)
May 16, 2013
Last Update Submitted That Met QC Criteria
May 13, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Uniko2010.01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchiectasis
-
Ruijin HospitalAstraZeneca Investment (China) Co., LtdNot yet recruitingBronchiectasis AdultChina
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Fondazione Policlinico Universitario Agostino Gemelli IRCCS; IRCCS Azienda... and other collaboratorsActive, not recruiting
-
University of Sao Paulo General HospitalEnrolling by invitation
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompletedBronchiectasis AdultBrazil
-
University of North Carolina, Chapel HillCompletedBronchiectasis AdultUnited States
-
Seoul National University Bundang HospitalUnknownSymptomatic BronchiectasisKorea, Republic of
-
Chang Gung Memorial HospitalNot yet recruitingBronchiectasis AdultTaiwan
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingBronchiectasis Adult
-
University of DundeeRecruitingBronchiectasis AdultUnited Kingdom
-
Papworth Hospital NHS Foundation TrustGlaxoSmithKlineCompletedBronchiectasis | Idiopathic BronchiectasisUnited Kingdom
Clinical Trials on Autogenic drainage
-
Cliniques universitaires Saint-Luc- Université...Recruiting
-
Cairo UniversityPrincess Nourah Bint Abdulrahman UniversityCompletedPostoperative ComplicationsEgypt
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Universidad San JorgeCystic Fibrosis FoundationCompletedCystic FibrosisSpain
-
Carmel Medical CenterRambam Health Care CampusUnknownBronchiectasisIsrael
-
Association Nationale pour les Traitements A Domicile...Recruiting
-
Riphah International UniversityCompletedPneumonia ChildhoodPakistan
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Vrije Universiteit BrusselCompleted